1. Introduction {#S1}
===============

A hallmark of the adaptive immune system is the ability of T cells, making use of the T cell receptors (TCRs) on their surface, to recognize a given agonist peptide--MHC ligand complex (pMHC) with high sensitivity ([@B1]). Some aspects of TCR--pMHC molecular interactions that are of current research interest are the frequency of encounters between T cells and the agonist pMHC, how cell--cell interactions determine the activation of lymphocytes ([@B2]), how early interactions change the state of the T cell receptor ([@B3]), what are the mechanisms of modulation of receptor--ligand interactions at cell--cell interfaces ([@B4]), and how protein organization in the cell membrane (for instance, protein islands or lipid rafts) affects the recognition process ([@B5]). Some recent experiments have explored the role of dimensionality on T cell activation and have highlighted the significance of the events taking place at the receptor level \[see Refs. ([@B1]) and ([@B6]) for comprehensive reviews\].

These open questions have been addressed with the use of mathematical modeling. Different theories can be classified according to the level of description ([@B7]). At the individual TCR--pMHC bond level, the kinetic proof-reading model ([@B8]) assumes that the TCR needs to undergo a series of consecutive (phosphorylation) steps before being triggered. Also at the TCR level, the optimal dwell time model ([@B9]) reconciles the concurrence of different timescales, providing an *optimal* timescale between the very short times related to the off rate of TCR--pMHC binding, and the long times related to kinetic proof-reading mechanisms. The TCR occupancy model ([@B10]) considers the cell as a *counting device* in which multiple TCR--pMHC interactions are required to activate a T cell. In a similar fashion, the serial triggering model ([@B11]) proposed that the same pMHC can engage *serially* different TCRs. This model enriches the viewpoint of the TCR occupancy model, by giving greater relevance to the role of the pMHC itself. Finally, the serial encounter model ([@B12]) and the confinement time model ([@B13]) combine several of the ideas above and provide some appealing explanations by relaxing some restrictions in those models.

While antigen presenting cells (APCs), such as dendritic cells or B cells, present 10^3^--10^4^ times more self-pMHC than antigenic pMHC, self-pMHC ligands by themselves do not usually elicit a T cell response, even though their affinity for TCR*αβ* is only 10 times lower than the affinity of the antigenic pMHC ([@B14]). This illustrates how a small difference in affinity results in high specificity, when there is only a few antigenic pMHC molecules in a background of self-pMHC ligands ([@B15]).

The T cell signaling process begins with (extracellular) TCR--pMHC binding, followed by phosphorylation of the intracellular ITAM domains of the TCR--CD3 complex. When a TCR binds a pMHC molecule, the TCR*αβ* hetero-dimer binds the peptide, while the CD4 or CD8 co-receptor binds the MHC molecule. The binding of the co-receptor activates the tyrosine kinase Lck, which phosphorylates the ITAMs of the CD3 complex. ITAM phosphorylation allows recruitment of intracellular signaling components that mediate downstream signaling events ([@B16]).

It has recently been suggested that, contrary to what happens in TCR micro-clusters and the immunological synapse, clustering is not only induced by the ligand but by an *avidity maturation* mechanism (or pre-clustering) ([@B17]), allowing the aggregation of chains of TCRs as long as 20 units (around 200 nm long), and referred to as *nano-clusters* ([@B3], [@B18]). Specifically, multimeric TCR--CD3 complexes are activated at low agonistic pMHC concentrations and monomeric TCRs remain unaffected at low ligand concentration. The TCR nano-clusters could enhance T cell sensitivity by the mechanisms proposed in the models of T cell activation ([@B7]), as their existence would reduce the time needed for two (or more) receptors to aggregate (by diffusion). This pre-cluster formation could be explained by three different mechanisms ([@B3]): Multimeric complexes (or clusters) enhance the TCR *avidity* toward the ligand, which is expressed in clusters on the surface of APCs ([@B19]--[@B21]). At low ligand concentration, only multimeric TCR clusters are bound to ligand, as TCR monomers require higher ligand concentration. Monomeric TCRs might only be activated at high agonist doses.Multimeric complexes allow the propagation of the activation signal from ligand-bound TCR*αβ* to neighboring receptors in the same TCR *multimer*.Linear arrays of multimeric TCR complexes help a single pMHC serially trigger several receptors ([@B11]).

The existence of these nano-clusters does not exclude additional mechanisms of T cell activation, as long as they involve the *cooperation* of receptors when they aggregate. Thus, while models such as kinetic proof-reading \[and improvements as described in Ref. ([@B22])\] operate at the level of a single receptor, other models might be used in combination with the fact that the pre-cluster distribution of naive and memory T cells is different.

Additionally, the fact that the TCR stoichiometry has not been resolved under physiological conditions, yet, makes it even more difficult to understand, at a molecular level, the dynamics of TCR pre-clustering ([@B23]). TCR pre-clustering could be an example of a more general mechanism of membrane-bound molecular pre-clustering, as clustering prior to cell--cell interaction has also been observed on the surface of APCs ([@B19]--[@B21]). It is worth mentioning that monomeric TCRs can still be activated at increasing ligand concentrations, thus, conferring the T cell with a capacity to generate a dose-dependent response at very high pMHC doses, when multimeric TCR--CD3 complexes are already saturated ([@B18]). Such mechanisms have been previously described for chemotactic bacteria, as a cellular mechanism to control sensitivity ([@B24]).

Various mechanisms have already been suggested, at the population, cellular or molecular level, to explain the capacity of T cells to respond, faster and more strongly, to a second antigenic encounter. However, the underlying mechanisms of the observed changes in the sensitivity of the T cell for pMHC ligand-mediated TCR stimulation ([@B25]) have not yet been clearly elucidated. Interestingly, the distribution of clusters in naive and memory T cells is different: memory T cells accommodate larger linear TCR clusters than naive ones. This could explain why memory T cells elicit more rapid responses than naive T cells ([@B17]) (see Figure [1](#F1){ref-type="fig"} below).

![**Distribution of TCRs at the surface of naive and memory T cells**. Resting naive and memory CD8^+^ OT-1 T cells were labeled with the CD3ϵ-specific mAb 2C11 and 10 nm gold-conjugated protein-A. Cell surface replicas of the labeled T cells were analyzed by transmission electron microscopy and the number and size of the observed gold clusters were recorded. **(A)** TEM image of surface replicas of a memory and a naive OT-1 T cell. The insets to the right show an enlargement of the boxed areas. **(B)** Quantification (mean ± SD) of gold particles in clusters of the indicated sizes for resting naive T cells (gray bars, 7 cells, 9190 particles) and memory T cells (black bars, 5 cells, 3001 particles). The inset shows a detailed view of the distribution of clusters of three or more gold particles and statistical analysis (2-tailed Student's *t*-test: \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001). All naive and memory T cells had clusters with gold. However, whereas in naive T cells the maximum gold cluster size shared by all cells was four, this was eight for memory T cells. Also clusters bigger than twenty three particles were present in four out of five memory T cells, and only two out of seven naive T cells.](fimmu-05-00132-g001){#F1}

In this paper, we explore the consequences of TCR pre-clustering in signaling and in distinguishing naive from memory T cell responses. We present some experimentally obtained distributions of TCR clusters for both types of cells (see Figure [1](#F1){ref-type="fig"}), and two complementary theoretical models: (i) a simple model of receptor oligomerization that describes cluster size distributions, and (ii) a generalization of the stochastic T cell response criterion of Ref. ([@B26]), to accommodate the hypothesis that the minimum signaling unit is composed of a TCR receptor cluster that is bound by the same cross-linked multivalent ligand. We find that this signaling unit is able to discriminate between agonist and antagonist pMHC ligands (with greater sensitivity than in the monomeric case), and to explain some of the advantages that higher cluster sizes can provide to memory T cells. The model also points at the need to invoke additional cooperativity mechanisms, to explain the experimentally observed role of clustering in T cell responses ([@B27]). Finally, this model of ligand-induced TCR cross-linking can be relevant in physiological conditions, according to the defective ribosomal products (DRiP) hypothesis ([@B28], [@B29]), which provides a rapid source of peptide precursors to optimize immuno-surveillance of pathogens and tumors ([@B30]).

2. Mathematical Modeling of TCR Pre-Clustering and T Cell Activation {#S2}
====================================================================

2.1. Model 1: T cell receptor pre-clustering {#S2-1}
--------------------------------------------

The TCR--CD3 complex consists of the pMHC binding TCR*αβ* hetero-dimer, associated with the hetero-dimers CD3*γϵ* and CD3*δϵ*, and the homo-dimer CD3*ζζ*. Binding of a stimulating pMHC ligand by the extracellular domain of TCR*αβ* results in conformational changes in the intracellular part of the CD3*ϵ* chain, and phosphorylation of the immuno-receptor tyrosine-based activation motifs (ITAMs) in the intracellular domains of the CD3*γϵ*, CD3*δϵ*, and CD3*ζζ* dimers, which in turn lead to initiation of downstream signaling cascades and T cell activation.

It has long been recognized that the TCR--CD3 complex forms clusters upon ligand binding ([@B31]--[@B36]). More recently, it has been shown that in the absence of stimulating pMHC ligand, TCR--CD3 complexes are already expressed at the cell surface as a combination of monomeric and oligomeric TCR complexes or TCR nano-clusters ([@B18]). Electron microscopy (EM) analysis of immuno-gold-labeled human and murine T cells showed that these nano-clusters consist of up to 20 TCR--CD3 complexes. The exact stoichiometry of the nano-clusters has not been resolved yet.

The integrity of TCR nano-clusters depends on cholesterol present at the cell surface membrane ([@B18]). The formation of the clusters depends, at least, on the trans-membrane region of the CD3*ζζ* homo-dimer ([@B17]), perhaps due to the capacity of *ζζ* dimers to form dimers of dimers ([@B37]). Other possible mechanisms of cluster formation rely on the capacity of the extracellular domain of TCR*α* to dimerize ([@B38]).

This body of experimental evidence allows us to conclude that multimeric TCR--CD3 complexes are co-expressed with TCR monomers on the surface of resting T cells.

A simple model of aggregation of TCR*αβ* units is depicted in the left panel of Figure [2](#F2){ref-type="fig"}. Given a chain of length *n* (with *n* hetero-dimers linked), in a small time interval Δ*t*, with probability *q*~+~ Δ*t*, the chain increases to length *n *+ 1, and with probability *q*~−~ Δ*t*, the chain decreases to length *n *− 1. Thus, by probability conservation, the probability to remain the same length *n* is 1 − (*q*~+~ + *q~−~*)Δ*t*.

![**Oligomerization and signaling models**. Left panel: oligomerization model not mediated by ligand (Model 1). We assume that receptors are able to diffuse and aggregate to an existing cluster. However, we exclude the possibility of clusters with size larger than one to diffuse. Clusters grow one monomeric unit at a time. Right panel: reactions included in the stochastic activation model (Model 2). Ligands in solution are able to attach monovalently to any receptor in a cluster (top reaction). In addition, ligand-induced TCR cross-linking can occur once a ligand is bound to a TCR in a given nano-cluster (bottom reaction). Following Ref. ([@B26]), once the bivalently bound ligand has been attached for a time *τ*, we count that state as a signaling unit. After *N* of these units have been generated, the cell becomes activated.](fimmu-05-00132-g002){#F2}

Mathematically, the dynamics of the process can be described by a continuous time Markov chain ([@B39]) (or birth and death process, as we assume that polymerization takes place in unit steps). The state space is {1, 2, 3, ..., *n* − 1, *n*, *n* + 1, ...}, where the number denotes the number of TCRs in a cluster: $$1\overset{q_{-}}{\underset{q_{+}}{\leftrightharpoons}}2\overset{q_{-}}{\underset{q_{+}}{\leftrightharpoons}}3\overset{q_{-}}{\underset{q_{+}}{\leftrightharpoons}}\cdots\overset{q_{-}}{\underset{q_{+}}{\leftrightharpoons}}n - 1\overset{q_{-}}{\underset{q_{+}}{\leftrightharpoons}}n\overset{q_{-}}{\underset{q_{+}}{\leftrightharpoons}}n + 1\cdots\mspace{460mu}.$$

The forward Kolmogorov equations for the probability of having a cluster of size *n* are given by ([@B40]) $$\begin{array}{rlrl}
\frac{dp_{n}\left( t \right)}{dt} & {= q_{+}p_{n - 1}\left( t \right) + q_{-}p_{n + 1}\left( t \right) - \left( {q_{+} + q_{-}} \right)p_{n}\left( t \right),\forall n \geq 2,\qquad} & & \qquad \\
\frac{dp_{1}\left( t \right)}{dt} & {= q_{-}p_{2{(t)}} - q_{+}p_{1}\left( t \right).\qquad} & & \qquad \\
\end{array}$$

The stationary probability distribution is then given by $$\begin{array}{rlrl}
 & {\underset{t\rightarrow+\infty}{lim}\, p_{n}\left( t \right) \equiv \pi_{n} = \frac{b^{n - 1}\left( {1 - b} \right)}{\left( {1 - b^{N_{\max}}} \right)}\quad,\qquad} & & \qquad \\
 & {\quad b < 1\mspace{2mu},\quad n \in \left\{ {1,2,3,\ldots,N_{\max}} \right\}\quad,} & & \\
\end{array}$$ with $b = \frac{q_{+}}{q_{-}}$, and *π~n~* the probability (in thermodynamic equilibrium) to have a cluster of size *n*. When *b* \< 1 (the number of clusters with a given size, *n*, decreases as *n* increases), and taking into account that peripheral T cells have around $N_{\max} \simeq 3 \times 10^{4}$ receptors, the latter expression can be further simplified to $$\pi_{n} = b^{n - 1}\left( {1 - b} \right)\mspace{9mu},\mspace{9mu} b < 1\mspace{9mu},\mspace{9mu} n \in \left\{ {1,2,3,\ldots} \right\}\mspace{9mu}.$$

2.2. Model 2: A bivalent model for T cell activation {#S2-2}
----------------------------------------------------

The TCR--pMHC binding model introduced in Ref. ([@B26]) considered monovalent pMHC ligands binding to TCR monomers on the surface of a T cell. Monovalent ligands have been reported to elicit a T cell response ([@B41]--[@B43]), but only when they are immobilized on a surface (which makes it difficult to assess whether they are truly monovalent or not). Yet, multivalent receptor--ligand interactions are required to elicit T cell responses in both CD4^+^ and CD8^+^ T cells. In what follows, and supported by a body of experimental work ([@B3], [@B24], [@B44]), we adopt the hypothesis that the minimum activating unit is a TCR--pMHC cross-linked dimeric complex ([@B31], [@B45]--[@B47]). We make use of the binding model (Model 2) with pMHC dimers (ligands) and dimeric TCRs (receptors), described in the right panel of Figure [2](#F2){ref-type="fig"}.

Gold-labeling experiments support the existence of nano-clusters with more than two TCRs, yet it can be shown (see Section [5.2](#S5-6){ref-type="sec"}) that the key parameter of the mathematical model is the fraction of monomeric to multimeric TCR clusters. Thus, without loss of generality, we will assume that all TCR clusters are dimeric.

The biochemical reactions encoded by the right panel of Figure [2](#F2){ref-type="fig"} are as follows: A (bivalent) ligand can bind a free receptor with monomeric binding reaction rates (*k*~on~ and *k*~off~). Although not shown in the figure, we allow for a second ligand to bind the free receptor of the cluster. However, at low concentrations of ligands, this reaction can be safely neglected.Cross-linking of a singly bound ligand follows with rates *k*~2~ (forward reaction) and *k*~−2~ (backward reaction).If the complex formed by the ligand cross-linked to the dimeric TCR cluster lasts at least a time *τ*, *dwell time*, we count that event. When we reach *N* such events, we will assume that a T cell response is initiated. The rationale behind this T cell response criterion follows the work of Palmer et al. ([@B48]), where the concepts of minimum dwell time and productive binding were introduced. This model combines aspects of the kinetic proof-reading ([@B8]) and the serial triggering models ([@B7], [@B11]). The minimum dwell time for a TCR--pMHC complex is the time the complex must remain bound in order to reach a level of ITAM phosphorylation, which will allow TCR triggering. Any binding, which persists for longer than the minimum dwell time is classified as a productive binding \[see Refs. ([@B48]) and ([@B26]) for further details\].From an immunological perspective, the relevant parameter is the *mean time to signal initiation*, or MTSI ([@B26]). Namely, the MTSI is the average time needed for a T cell response according to the criterion that at least *N* TCR dimers should be bivalently engaged to a bivalent ligand (pMHC) for at least a time *τ*.

Here we assume that *N* is around 10--100. That is, 10--100 TCRs are required for signaling and *N~B~* = *b *× *N~R~* is of the order of 10^4^, with *N~B~* the total number of clusters on the T cell surface. This means, under the assumptions of Model 2, that at most, there can be *N* = 100 internalization events, as this is the number of triggered TCRs. Thus, in this approximation, the loss of TCR due to internalization after triggering can be safely neglected. Nevertheless, internalization is an important step in early signaling, and a proper mechanistic model to justify the value of *τ* will require internalization to be considered. This analysis is out of the scope of this article.

We implement these reactions as a Markov process, and solve them numerically using the standard Gillespie algorithm ([@B49]), and with the parameters summarized in Table [1](#T1){ref-type="table"}. We have made use of three different ligands: 4A, 4P, and 4N, which were also used in Ref. ([@B26]). For these ligands, that bind the same TCR with different affinities, a simple estimation of the number of cross-linking events required to elicit a T cell response is summarized in Table [2](#T2){ref-type="table"}.

###### 

**Summary of the parameters used in the stochastic simulations**.

  Parameter   Value                                               Comment
  ----------- --------------------------------------------------- -----------------------------------------------------------------------------
  *N~A~*      6.023 × 10^23^                                      Avogadro's number
  *N~R~*      30,000                                              Average number of TCRs per T cell ([@B34] )
  *V*         50 μl                                               Volume of the experiment
  *N~C~*      10^5^ cells                                         Number of T cells in the experiment
  *V~C~*      *V*/*N~C~*                                          Average extracellular volume per cell
  *k*~−2~     *k*~off~                                            Cross-linking off rate
  *k*~2~      $k_{off}\left( k_{d}\slash k_{d}^{dimer} \right)$   Cross-linking rate[^a^](#tfn1){ref-type="table-fn"}
  *N*         10                                                  Minimum number of bound dimer-bivalent clusters to elicit a T cell response
  τ           1--4 s                                              Dwell time

*For typical values of the dissociation rate, *k~d~*, we find that *k*~2~ is about 10--50 times *k*~off~. We have assumed *k*~−2~ = *k*~off~ following Ref. ([@B44]). When not explicitly shown, we have used the same parameters as in Ref. ([@B26])*.

*^a^The cross-linking rate *k*~2~ is adapted from Ref. ([@B44]) for bivalent receptors*.

###### 

**Estimated mean number of cross-linking events, $N^{\prime} \simeq N\, e^{2k_{- 2^{\tau}}}$, required to elicit a T cell response (SP thymocytes)**.

  Ligand                            *N*′              
  --------------------------------- ------ ---------- ----------
  4P                                1      3          12
  (*k*~on~ = 153,691 M^−1^ s^−1^)   4      3          13
  (*k*~off~ = 0.0169 s^−1^)         8      3          14
  4A                                1      7          58
  (*k*~on~ = 157,533 M^−1^ s^−1^)   4      \~10^3^    \~10^4^
  (*k*~off~ = 0.8664 s^−1^)         8      \~10^6^    \~10^7^
  4N                                1      \~10^7^    \~10^8^
  (*k*~on~ = 149,385 M^−1^ s^−1^)   4      \~10^30^   \~10^31^
  (*k*~off=8.6643~ s^−1^)           8      \~10^60^   \~10^61^

There is some evidence that, under physiological conditions, the chance of two specific peptides being presented by two MHC molecules in sufficient proximity and long enough to act as a dimer is very small ([@B46]). This will make ligand-induced TCR cross-linking a rare event. However, some recent experimental work on the distribution of cognate pMHC molecules on the surface of APCs shows that both for MHC class I (virus infection models), and for MHC class II (antigen uptake via the endocytic route) clusters of cognate pMHC can be detected ([@B19]--[@B21]).

We also note that ligand concentration is not the only factor that depends on physiological conditions. According to the DRiP hypothesis ([@B28], [@B29]), rapid viral antigen presentation is possible because antigenic peptides originate from defective ribosomal products that have short half-lives. Although this phenomenon affects the time between viral challenge and antigen presentation, we assume it is independent of the subsequent signaling dynamics of T cell activation.

3. Results {#S3}
==========

3.1. Distribution of TCR clusters {#S3-3}
---------------------------------

The mathematical model described in Section [2.1](#S2-1){ref-type="sec"}, or Model 1, allows us to obtain the value of *b* that best fits the experimental data. We have used a weighted (by the variance) minimum-square regression to fit the experimental distributions to equation (2). This kind of fit minimizes the value of *χ*^2^. Thus, in Figure [3](#F3){ref-type="fig"}, we show the agreement between theory and experiment, with values: *b*~naive~ = 0.32 and *b*~memory~ = 0.55. The difference between *b*~naive~ and *b*~memory~ can be explained by the existence of larger (or at least more localized) lipid rafts on the membrane of memory T cells ([@B50], [@B51]). Thus, the rates *q*~±~could be the effective combination of two mechanisms: one related to the diffusion of receptors on the membrane, and the other related to the aggregation of the receptors at the molecular level. The presence of cholesterol on the membrane changes the diffusion coefficient of the TCR receptors, as receptor diffusion within the raft is inhibited due to protein anchorage ([@B52]) and, thus, stabilizes the formation of clusters (a larger value of *b* means that, once two receptors are embedded in the same lipid raft, it is more difficult for them to become separated from each other).

![**Comparison between the experimental distribution of clusters (see also Figure [1](#F1){ref-type="fig"}) and those from Model 1 for (A) naive T cells and (B) memory T cells**. The theoretical distribution has been fitted to equation ([2](#E2){ref-type="disp-formula"}) using a weighted (by the variance) minimum-square regression. The fitted values are *b*~naive~ = 0.32 and *b*~memory~ = 0.55.](fimmu-05-00132-g003){#F3}

A consequence of Model 1 is that, as the stationary probabilities need to sum up to one, the fraction of clusters of size larger than one is, precisely, *b*. This fraction is 72% higher for memory T cells than for naive T cells: *b*~memory~/*b*~naive~ = 1.72.

3.2. Mean time to signal initiation {#S3-4}
-----------------------------------

In Figures [4](#F4){ref-type="fig"}A--D, we show how the stochastic criterion is able to provide a ligand hierarchy according to their *potency*. Namely, the most agonistic ligand, 4P, elicits a T cell response in times of the order of a few seconds in all cases. On the contrary, the most antagonistic ligand, 4N, takes extremely large times to do so (in practical terms, this means it does not elicit a T cell response). Thus, TCR clustering can enhance the *potency* of ligands, when compared to the monomeric case ([@B26]), as experimentally observed and theoretically shown.

![**Dependence of the mean time to signal initiation (MTSI), *T*(*N*, *τ*) to have *N* cross-linked ligand--receptor complexes bound for at least a dwell time *τ* for different model parameters as shown in every panel**. The results have been obtained by making use of a Gillespie algorithm, after averaging over 100 realizations for each set of the parameters, summarized in Table [2](#T2){ref-type="table"} (a python code for the stochastic integration is available upon request). Units of time are seconds. All parameters are taken from Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} except **(A)** *N* = 10, τ = 1 and *k*~2~ = 10 × *k*~off~; **(B)** *N* = 10, τ = 1 and *k*~2~ = 40 × *k*~off~; **(C)** *N* = 10, τ = 4 and *k*~2~ = 10 × *k*~off~; **(D)** *N* = 10, τ = 4 and *k*~2~ = 40 × *k*~off~.](fimmu-05-00132-g004){#F4}

Following a similar approach to that of Ref. ([@B26]), we can derive an approximate formula for the mean time to signal initiation (MTSI), *T*(*N*, *τ*), for different ranges of ligand concentration, *ρ*. We write (see Figure [5](#F5){ref-type="fig"}A and Section [5.3](#S5-7){ref-type="sec"} for further details): $$\begin{array}{r}
{T\left( {N,\tau} \right) \simeq \begin{cases}
{\tau\quad} & {{at}\mspace{9mu}{high}\mspace{9mu}{concentration}} \\
{\tau + \left\lbrack \frac{N\text{ exp}\left( {2k_{-2}\tau} \right)}{2\rho N_{B}k_{{on}k_{2}}} \right\rbrack^{1 \slash 2}\quad} & \begin{array}{l}
{{at}\mspace{9mu}{intermediate}\mspace{9mu}{concentration}} \\
\end{array} \\
\quad & \\
{\tau + \frac{N\exp\left( {2k_{- 2}\tau} \right)}{4\rho N_{B}k_{on}\left( k_{2}\slash k_{- 2} \right)}\quad} & {{at}\mspace{9mu}{low}\mspace{9mu}{concentration}} \\
\quad & \\
\end{cases}} \\
\end{array}$$

![**(A)** Comparison of the numerical solution of Model 2 (Gillespie algorithm with the parameters summarized in Table [2](#T2){ref-type="table"}) and the approximate solution \[equation ([3](#E3){ref-type="disp-formula"})\] for ligand 4P and the same parameters as in Figure [4](#F4){ref-type="fig"}. **(B)** Comparison of the mean MTSI for naive (red dashed line) and memory (solid black line) T cells.](fimmu-05-00132-g005){#F5}

These three regimes correspond to different immunological scenarios. In the case of high concentration of ligand, ligand is in great excess, so that the required number of *signaling units* is reached, almost as soon as the first signaling unit is formed (time of order *τ*). At low ligand concentration, the dynamics is limited by the first binding event, as cross-linking occurs in a slower timescale. So, the MTSI has the same functional form as that for the monomeric case ([@B26]). Finally, for intermediate ligand concentration, the competition between binding and cross-linking implies a more complicated mathematical relationship. Of greater relevance to the discussion is the nature of the ligand (with different *k*~on~ and *k*~off~ rates), and the number of TCR clusters on the membrane of the T cell (encoded in the parameter *N~B~* = *b *× *N~R~*, with *N~R~*, the average number of TCRs per T cell, see Table [1](#T1){ref-type="table"}).

An expression for the variance of the time to signal initiation (TSI) cannot be provided in a closed form \[as done in Ref. ([@B26])\]. However, the fact that the variance decreases as the ligand concentration increases, suggests that the mathematical formula for the variance in the monovalent case can provide an upper bound to the present (dimeric) case.

Using equation ([3](#E3){ref-type="disp-formula"}), we also can deduce the role of pre-clustering in the signaling time, or MTSI. As the number of bivalent clusters is *b *× *N~R~*, the larger *b* is, the shorter the response time becomes. The model predicts that, for physiological conditions (not too high ligand concentrations), the ratio of the MTSI for naive and memory T cells is inversely proportional to the ratio of their corresponding values of *b*. Namely, memory cells would respond up to 72% faster than naive ones (Figure [5](#F5){ref-type="fig"}B).

4. Discussion {#S4}
=============

TCR triggering mechanisms are currently under debate \[see, for example, Ref. ([@B53]) and ([@B7]) for recent reviews\]. TCR clustering may be invoked as a description of the experimental results ([@B27]). The requirement for multivalent engagement of TCRs by pMHC ligands in CD4^+^ T cells has been widely shown ([@B45], [@B47], [@B54], [@B55]). The same requirement was shown in CD8^+^ T cells by Stone and Stern ([@B56]).

In this paper, we have made use of the concept of *mean time to signal initiation* (MTSI or stochastic criterion) as a method to quantify the effect of TCR clustering on the timescales of T cell responses and, thus, to compare the behavior of naive and memory T cells. This criterion has also allowed us to compare the results in Section [3](#S3){ref-type="sec"} for dimeric binding with those of Ref. ([@B26]) for monomeric binding. The introduction of the cross-linked ligand--receptor complex as the minimum *signaling* unit gives the response greater sensitivity to small differences in ligand affinity.

A recent and novel feature of TCR immunology is the existence of TCR nano-clusters that are pre-formed, independently of ligand ([@B3]). This suggests that a simple stoichiometric clustering model (oligomerization of free TCRs diffusing on the T cell membrane) is enough to account for the distribution of TCR nano-clusters. In the case of naive T cells, Model 1 predicts an effective non-dimensional parameter, *b* = *q*~+~/*q*~−~, that allows us to explain the experimentally observed TCR cluster distributions. The presence of larger lipid rafts on the membrane of memory T cells might provide support for the different values of *b* for naive and memory cells, *b*~naive~ and *b*~memory~, respectively. It has recently been shown that receptor diffusion within the raft is inhibited due to protein anchorage ([@B52]). This reduction in the TCR diffusion coefficient would increase the time required for the receptor to escape from the raft \[in a similar fashion as other escape problems ([@B57])\]. This escape time is inversely proportional to the diffusion coefficient itself. A smaller TCR diffusivity, as would be the case for memory T cells, will imply a larger residence time in the raft, which in turn will increase the probability of receptor aggregation in a given TCR cluster. A more detailed model of TCR diffusion and aggregation on the T cell membrane will be the subject of future work.

Equation ([3](#E3){ref-type="disp-formula"}) shows the explicit dependence of the MTSI, *T*(*N*, *τ*), on the parameter *N~B~*, for given values of *N* and *τ*. *N~B~* is the average number of dimeric receptor clusters per T cell, so that *N~B~* = *b *× *N~R~*, with *N~R~*, the average number of TCRs per T cell (see Table [1](#T1){ref-type="table"}). For large ligand concentration, the predicted T cell response time for memory and naive T cells is the same, and is equal to *τ*. In the case of intermediate concentrations, the MTSI is proportional to $\frac{1}{\sqrt{b}}$. Finally, for low ligand concentration the MTSI is proportional to $\frac{1}{b}$. This implies that, at low ligand concentration, TCR pre-clustering alone can only account for at most 72% of the reduction in the response time between memory and naive T cells. This behavior is illustrated in Figure [5](#F5){ref-type="fig"}A. This difference is not so large as to be able to account for the observed higher responsiveness of memory T cells. Our results, thus, point to the need for additional mechanisms beyond TCR pre-clustering.

A potential candidate to explain the large differences between memory and naive T cell responses is the conformational change of the CD3 complex ([@B58]). This conformational change is essential to enable ITAM phosphorylation and, thus, the transfer of the TCR signal from the ecto-domain to the cytoplasmic tail of the TCR ([@B58]). Conformational changes in the CD3 complex occur as a result of the *αβ* hetero-dimer binding to pMHC. These conformational changes allow the subunits of the CD3 complex (the *γϵ* and *δϵ* hetero-dimers and the *ζζ* homo-dimer) to become accessible to Lck, which can then phosphorylate their cytoplasmic domains at the ITAMs, leading to T cell signaling ([@B59]). In this way, the ligand-induced conformational change of the receptors can be propagated to all the receptors in the same cluster, so that larger clusters would benefit from this conformational change as a *cascade* \[see, for example, Ref. ([@B60]) and references therein\]. Thus, differences in the distribution of cluster sizes could, indeed, explain the immunological differences between memory and naive cells.

Other membrane receptors also exhibit pre-clustering and ligand-induced receptor cross-linking. For instance, in the case of the vascular endothelial growth factor receptor (VEGFR), it has been shown ([@B61]) that there are two distinct pathways to receptor dimerization: (i) dynamic pre-dimerization (as the one described in Model 1), and (ii) ligand-induced receptor dimerization. The main conclusion in Ref. ([@B61]) is that both mechanisms are almost indistinguishable at low ligand concentration. However, the first mechanism is more sensitive to changes in the binding affinity at large ligand concentration. Although the biological system studied in Ref. ([@B61]) is different from the T cell receptor considered here, their conclusions might be generalized as both receptors are tyrosine kinases.

Bachmann et al. ([@B62], [@B63]) considered a model of diffusion and ligand-induced TCR clustering. Their model suggests that the existence of large enough clusters greatly inhibits subsequent multimer diffusion, thus, reducing the relevance that this mechanism might have. This inhibition might be experimentally tested by exploiting the differences between naive (small and few clusters) and memory (large and many clusters). It will be interesting to make use of the models introduced in this paper to investigate the different roles of ligand binding and cellular activation ([@B62]), and TCR turnover ([@B64]).

Finally, the existence of TCR pre-clusters \[and the knowledge of their membrane distribution given by *π~n~*, equation ([2](#E2){ref-type="disp-formula"})\] can be considered in the kinetic-segregation model ([@B65]). In this model, diffusion out of close-contact zones would be inhibited by the existence of nano-clusters, thus, enhancing the number of triggered receptors. In a similar way, consecutive receptor phosphorylation events ([@B66]) in TCR nano-clusters would also amplify receptor signaling.

5. Materials and Methods {#S5}
========================

5.1. Experiments {#S5-5}
----------------

Naive CD8^+^ OT-1 T cells, which recognize an ovalbumin-derived peptide presented by the MHC class I molecule H-2K^b^, were isolated from superficial and mesenteric lymph nodes of OT-1 TCR transgenic mice ([@B67]), via depletion of CD19^+^ B cells, CD4^+^ helper T cells and CD11b^+^ macrophages, using antibodies and Dynal magnetic beads (Invitrogen). Memory OT-1 T cells were generated by adoptively transferring 10^6^ naive OT-1 T cells into congenic C57BL/6 Ly5.1 Pep3b mice, which were simultaneously immunized with 10^7^ PFU MVA-OVA ([@B68]). After 6 months, resting memory OT-1 T cells were isolated from the spleen and lymph nodes of these mice by antibody-mediated depletion of macrophages, B cells, and CD4^+^ T cells, followed by separation of the OT-1 memory T cells from host-derived Ly5.1^+^ CD8^+^ T cells via fluorescence-activated cell sorting, using a Ly5.1-specific antibody. Labeling of cells with the CD3*ϵ*-specific antibody 2C11 and 10 nm gold-conjugated protein-A, replica generation and analysis were performed as previously described ([@B17]).

5.2. Models of signaling with dimeric and trimeric receptor clusters {#S5-6}
--------------------------------------------------------------------

In Section [2](#S2){ref-type="sec"}, we introduced a model in which ligands are bivalent and receptor clusters are dimeric (that is, composed of two monomeric TCRs). This is, of course, a first approximation that neglects the distribution of cluster sizes experimentally observed. Yet, the results of our mathematical study only change in a quantitative way, but not qualitatively, when we include TCR clusters of larger sizes. In this Section, we illustrate this by considering a system in which clusters of size 1, 2, and 3 coexist and the ligands are bivalent. Table [3](#T3){ref-type="table"} provides the notation introduced to describe the molecular species considered in the model, as well as a graphical representation.

###### 

**Summary of variables for a model in which clusters of size 1, 2, and 3 coexist**.

  Variable   Description                                                              Molecular representation
  ---------- ------------------------------------------------------------------------ ------------------------------
  *z*~1~     Free monomeric receptor                                                  ![](fimmu-05-00132-i001.jpg)
  *z*~2~     Free ligand (dimer)                                                      ![](fimmu-05-00132-i002.jpg)
  *z*~3~     Ligand-bound to a monomeric receptor                                     ![](fimmu-05-00132-i003.jpg)
  *x*~1~     Free dimeric cluster                                                     ![](fimmu-05-00132-i004.jpg)
  *x*~2~     Same as *z*~2~ (defined for convenience of notation)                     ![](fimmu-05-00132-i005.jpg)
  *x*~3~     Ligand singly bound to a dimeric cluster                                 ![](fimmu-05-00132-i006.jpg)
  *x*~4~     Two ligands bound to a dimeric cluster                                   ![](fimmu-05-00132-i007.jpg)
  *x*~5~     Cross-linked ligand in a dimeric cluster                                 ![](fimmu-05-00132-i008.jpg)
  *y*~1~     Free trimeric receptor                                                   ![](fimmu-05-00132-i009.jpg)
  *y*~2~     Same as *z*~2~ (defined for convenience of notation)                     ![](fimmu-05-00132-i010.jpg)
  *y*~3~     Ligand singly bound to a trimeric cluster                                ![](fimmu-05-00132-i011.jpg)
  *y*~4~     Two ligands bound to a trimeric cluster                                  ![](fimmu-05-00132-i012.jpg)
  *y*~5~     Cross-linked ligand in a trimeric cluster                                ![](fimmu-05-00132-i013.jpg)
  *y*~6~     Three ligands bound to a trimeric cluster                                ![](fimmu-05-00132-i014.jpg)
  *y*~7~     One ligand singly bound to a trimeric cluster and another cross-linked   ![](fimmu-05-00132-i015.jpg)

*All the variables correspond to the total number of molecular species (not concentrations). Hence, all the rates in the mathematical model have units of s^−1^*.

At large initial ligand concentration, under the stochastic criterion, the MTSI tends to *τ*. On the other hand, at low initial ligand concentration, the number of receptors, compared to the number of ligands, is so large that we can neglect molecular species *x*~4~, *y*~4~, *y*~6,~ and *y*~7~, which involve more than one bivalent ligand. This has also been confirmed experimentally. Given our stochastic T cell response criterion, in this case, the signaling units correspond to molecular species *x*~5~, *y*~5~, and *y*~7~. Molecular species *z*~1~ and *z*~3~ do not contribute to the T cell response and will be neglected in what follows. Thus, we only need to consider the dynamics of dimeric and trimeric T cell receptor clusters.

We introduce the total number of *signaling units*, $S_{5}\left( t \right) \equiv x_{5}\left( t \right) + y_{5}\left( t \right)$. The set of ordinary differential equations for the model is given by: $$\begin{array}{rlrl}
 & {ẋ_{1} = - 4k_{+}x_{1}x_{2} + k_{off}\, x_{3},\qquad} & & \qquad \\
 & {ẋ_{2} = - 4k_{+}x_{1}x_{2} + k_{off}\, x_{3},\qquad} & & \qquad \\
 & {ẋ_{3} = 4k_{+}x_{1}x_{2} - k_{off}\, x_{3} - k_{2}x_{3} + 2k_{- 2}x_{5},\qquad} & & \qquad \\
 & {ẋ_{5} = k_{2}x_{3} - 2k_{- 2}x_{5},\qquad} & & \qquad \\
 & {ẏ_{1} = - 6k_{+}y_{1}y_{2} + k_{off}\, y_{3},\qquad} & & \qquad \\
 & {ẏ_{2} = - 6k_{+}y_{1}y_{2} + k_{off}\, y_{3},\qquad} & & \qquad \\
 & {ẏ_{3} = 6k_{+}y_{1}y_{2} - k_{off}\, y_{3} - 2k_{2}y_{3} + 2k_{- 2}y_{5},\qquad} & & \qquad \\
 & {ẏ_{5} = 2k_{2}y_{3} - 2k_{- 2}y_{5},\qquad} & & \qquad \\
\end{array}$$ where *k*~+~ = *k*~on~/(*VN~A~*), *V* is the volume of the experiment and *N~A~* is Avogadro's number.

Given the symmetry of the problem, and in the limit of low initial ligand concentration, we will assume that the ratio of *x*~3~ to *y*~3~ is that of the initial ratio of free TCR dimers to free TCR trimers, namely, $$\left. \frac{y_{3}}{x_{3}} \simeq \frac{\pi_{3}}{\pi_{2}} = b\quad\Rightarrow\quad y_{3} \simeq b\mspace{9mu} x_{3}\mspace{9mu}, \right.$$ where we have made use of equation ([2](#E2){ref-type="disp-formula"}) to conclude $\frac{\pi_{3}}{\pi_{2}} = b$. Thus, the total number of signaling units, *S*~5~(*t*), obeys the following differential equation $$Ṡ_{5} = ẋ_{5} + ẏ_{5} = k_{2}\mspace{9mu}\left( {1 + 2b} \right)\mspace{9mu} x_{3} - 2\mspace{9mu} k_{- 2}\mspace{9mu} S_{5}\mspace{9mu}.$$

Finally, in the low ligand concentration limit as above, let us introduce $S_{3} \equiv x_{3} + y_{3}$. It is easy to show that equation ([5](#E5){ref-type="disp-formula"}) reduces to $$Ṡ_{5} = k_{2}\mspace{9mu}\frac{1 + 2b}{1 + b}\mspace{9mu} S_{3} - 2\mspace{9mu} k_{- 2}\mspace{9mu} S_{5}\mspace{9mu},$$ which is identical to the differential equation for *x*~5~ above, but with *S*~5,3~ replaced by *x*~5,3~, respectively. This means that, except for a pre-factor $\frac{1 + 2b}{1 + b}$ \[which, for *b* ∈ (0, 1), is between 1 and 3/2\], the study of dimeric and trimeric clusters is reduced to the dimeric case.

5.3. A simple formula for the MTSI {#S5-7}
----------------------------------

The basic idea behind the stochastic criterion is to count the cumulative number of events that may contribute to signaling ([@B26]). Here, we calculate the mean number of cross-linking events up to time *t*, *C*(*t*), as the integral, $$C\left( t \right) = k_{2}\int_{0}^{t}\, x_{3}\left( s \right)\mspace{9mu} ds\mspace{9mu}.$$

It is possible to obtain an expression for *x*~3~(*t*) with the approximation that the product *x*~1~(*t*)*x*~2~(*t*) is constant, so that the pair of equations for *x*~3~(*t*) and *x*~5~(*t*) can be solved exactly. This yields ([@B69]): $$\begin{array}{rlrl}
{C\left( t \right)} & {= k_{2}\left\lbrack {\frac{c_{1}}{\lambda_{1}}\left( {\lambda_{1} + 2k_{- 2}} \right)\left( {e^{\lambda_{1}t} - 1} \right)} \right.\qquad} & & \qquad \\
 & {\left. {\quad + \frac{c_{2}}{\lambda_{2}}\left( {\lambda_{2} + 2k_{- 2}} \right)\left( {e^{\lambda_{2}t} - 1} \right) + a_{1}t} \right\rbrack\quad,} & & \\
\end{array}$$ where $$\begin{array}{rlrl}
c_{1} & {= \frac{- 4\lambda_{2}k_{on}\rho N_{B}}{\left( {\lambda_{2} - \lambda_{1}} \right)\left( {4k_{on}\rho k_{2} + 2k_{off}k_{- 2} + 8k_{on}\rho k_{- 2}} \right)}\quad,\qquad} & & \qquad \\
c_{2} & {= \frac{4\lambda_{1}k_{on}\rho N_{B}}{\left( {\lambda_{2} - \lambda_{1}} \right)\left( {4k_{on}\rho k_{2} + 2k_{off}k_{- 2} + 8k_{on}\rho k_{- 2}} \right)}\quad,\qquad} & & \qquad \\
\lambda_{1,2} & {= \frac{1}{2}\left( {- 4k_{on}\rho - k_{off} - k_{2} - 2k_{- 2}} \right.\qquad} & & \qquad \\
 & {\left. {\quad \pm \left\lbrack {\left( {4k_{on}\rho + k_{off} - k_{2} - 2k_{- 2}} \right)^{2} + 4k_{off}k_{2}} \right\rbrack^{1 \slash 2}} \right)\quad,\qquad} & & \qquad \\
a_{1} & {= \frac{8k_{- 2}k_{on}\rho N_{B}}{4k_{on}\rho k_{2} + 2k_{off}k_{- 2} + 8k_{on}\rho k_{- 2}}\quad,\qquad} & & \qquad \\
a_{2} & {= \frac{4k_{2}k_{on}\rho N_{B}}{4k_{on}\rho k_{2} + 2k_{off}k_{- 2} + 8k_{on}\rho k_{- 2}}\quad,\qquad} & & \qquad \\
\end{array}$$ and *N~B~* is the number of dimeric receptors. The MTSI is then given by the solution of the equation *C*(*T*(*N*, *τ*)--*τ*) = *N* exp(2*k*~−2~*τ*).

The expressions in equation ([3](#E3){ref-type="disp-formula"}) are obtained from equation ([8](#E8){ref-type="disp-formula"}) in the appropriate regimes. At low ligand concentration, *C*(*t*) is simply proportional to time: $C\left( t \right) \simeq k_{2}a_{1}t$, so that *C*(*T *− *τ*) = *k*~2~*a*~1~(*T *− *τ*) = *N* exp(2*k*~−2~*τ*). When *λ*~1,2~*τ* ≪ 1, on the other hand, the first non-zero term in a Taylor expansion of *C*(*t*) in time is quadratic: *C*(*t*) *∝ t*^2^. This provides the exponent 1/2 in the second line of equation ([3](#E3){ref-type="disp-formula"}).

Conflict of Interest Statement {#S6}
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

We thank Ed Palmer, Wolfgang Schamel, and Thomas Höfer for helpful discussions. We also thank the Max Planck Institute for the Physics of Complex Systems (Dresden) and the International Centre for Mathematical Sciences (Edinburgh), where part of this work was discussed and presented, for their hospitality. This work has been partially supported through Grants No. FIS2009-12964-C05-03 (Mario Castro, Grant Lythe, Carmen Molina-París), BFU2009-08009 from the Ministerio de Ciencia e Innovación (Hisse M. van Santen), FP7 PIRSES-GA-2008-230665 and PIRSES-GA-2012-317893 (Mario Castro, Grant Lythe, and Carmen Molina-París), BBSRC BB/F003811/1 (Grant Lythe and Carmen Molina-París), and BBSRC BB/G023395/1 (Carmen Molina-París).

[^1]: Edited by: Rob J. De Boer, Utrecht University, Netherlands

[^2]: Reviewed by: Daniel Coombs, University of British Columbia, Canada; Barbara Szomolay, University of Warwick, UK

[^3]: This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology.
